|
Our Mission
We develop medicines that boost the patients' own immune system to live a longer and better life and change the treatment paradigm in the field of chronic infections, cancer and allergy.
Our Company
Genetic Immunity, a wholly owned subsidiary of Power of the Dream Ventures, Inc (Ticker: PWRV) is an US / Hungarian clinical-stage biotechnology company focusing on the discovery, development and commercialization of personalized Immune Therapies (Therapeutic Vaccines). Our Products are designed to boost specific immune responses to modify or control these presently incurable diseases. more»
ISO 9001:2008
Genetic Immunity has been certified for Biotechnological product development: research and development, clinical trials. more»
|
|
|
Latest Press Release
|
|
» Oct 22, 2012
Genetic Immunity Publish the Technology Roadmap for the Cure of HIV
( Click here to read the press release... )
|
News Highlights
|
|
» January 02, 2013
Julianna Lisziewicz, president and CEO of the Genetic Immunity, was interviewed on the VLP meeting in November in Cannes
» September 28, 2012
Amerikai Tőzsdén a Genetic Immunity
» August 20, 2012
Topol on The Creative Destruction of Medicine
» August 03, 2012
Cure of AIDS?
|
|
Platform Highlights
 » Clinical Studies with DermaVir
Our first Phase II study reached the primary endpoint and shows excelent safety, tolerability and preliminary efficacy... more»
 » DermaPrep Medical Device
CE Mark was obtained for our DermaPrep transdermal delivery device ... more»
 » Nanomedicine
Our Nanomedicine Antigen Composition technology creates pathogen-like nanoparticles from antigens. more»
 » ANTIGENeering
Our single pDNA API expresses several antigens and VLP+. more»
|
